Cleveland BioLabs and Incuron Announce Notice of Allowance From FDA to Commence Clinical Testing With CBL0137

[at noodls] – Download PDF BUFFALO, N.Y., April 2, 2013 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced … more

View todays social media effects on CBLI

View the latest stocks trending across Twitter. Click to view dashboard

See who Cleveland is hiring next, click here to view